The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4

The efficacy of the novel fluoroquinolone finafloxacin was evaluated as a potential therapeutic in vitro and in vivo, following an intranasal infection of Francisella tularensis strain SchuS4 in BALB/c mice. We demonstrated that short treatment courses of finafloxacin provide high levels of protecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Microbiol
Main Authors: Barnes, Kay B., Hamblin, Karleigh A., Richards, Mark I., Laws, Thomas R., Vente, Andreas, Atkins, Helen S., Harding, Sarah V.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6504792/
https://ncbi.nlm.nih.gov/pubmed/31118924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2019.00904
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados